Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jennifer Sharpe Potter, Ph.D.

Title
Institution
Department
Address
Phone
Fax

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. R42DA054881 (POTTER, JENNIFER SHARPE) Sep 14, 2018 - Aug 31, 2024
    NIH
    mHealth for Patient Self-Management of Opioid Use Disorder
    Role: Principal Investigator
  2. K23DA022297 (POTTER, JENNIFER SHARPE) Apr 1, 2008 - Mar 31, 2015
    NIH
    Treatment of Opioid Dependence and Chronic Pain
    Role: Principal Investigator
  3. UG1DA020024 (TRIVEDI, MADHUKAR H.) Sep 1, 2005 - Feb 28, 2025
    NIH
    NIDA Clinical Trials Network: Big South/West Node
    Role: Co-Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Potter JS, Finley EP, King VL, Lanham HJ, Schmidt S, Schneegans S, Rosen KD. Adapting and scaling a single site DEA X-waiver training program to a statewide initiative: Implementing GetWaiveredTX. J Subst Abuse Treat. 2022 06; 137:108688. PMID: 35058105; PMCID: PMC9086104.
    Citations: 1     Fields:    Translation:Humans
  2. Finley EP, Schneegans S, Curtis ME, Bebarta VS, Maddry JK, Penney L, McGeary D, Potter JS. Confronting challenges to opioid risk mitigation in the U.S. health system: Recommendations from a panel of national experts. PLoS One. 2020; 15(6):e0234425. PMID: 32542028.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  3. Rosen KD, Curtis ME, Potter JS. Pain, psychological flexibility, and continued substance use in a predominantly hispanic adult sample receiving methadone treatment for opioid use disorder. Drug Alcohol Depend. 2020 01 01; 206:107681. PMID: 31711875; PMCID: PMC6980701.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  4. Flores J, Liang Y, Ketchum NS, Turner BJ, Bullock D, Villarreal R, Potter JS, Taylor BS. Prescription Opioid Use is Associated with Virologic Failure in People Living with HIV. AIDS Behav. 2018 04; 22(4):1323-1328. PMID: 28688032.
    Citations: 8     Fields:    Translation:Humans
  5. Phelps CL, Paniagua SM, Willcockson IU, Potter JS. The relationship between self-compassion and the risk for substance use disorder. Drug Alcohol Depend. 2018 02 01; 183:78-81. PMID: 29241104.
    Citations: 5     Fields:    Translation:Humans
  6. Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, Carroll KM, Potter JS, Wiest K, Mooney LJ, Hasson A, Walsh SL, Lofwall MR, Babalonis S, Lindblad RW, Sparenborg S, Wahle A, King JS, Baker NL, Tomko RL, Haynes LF, Vandrey RG, Levin FR. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend. 2017 08 01; 177:249-257. PMID: 28623823.
    Citations: 51     Fields:    Translation:HumansAnimals
  7. Ramirez S, Bebarta VS, Varney SM, Ganem V, Zarzabal LA, Potter JS. Misuse of Prescribed Pain Medication in a Military Population-A Self-Reported Survey to Assess a Correlation With Age, Deployment, Combat Illnesses, or Injury? Am J Ther. 2017 Mar/Apr; 24(2):e150-e156. PMID: 26963723.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  8. Smallwood RF, Potter JS, Robin DA. Neurophysiological mechanisms in acceptance and commitment therapy in opioid-addicted patients with chronic pain. Psychiatry Res Neuroimaging. 2016 Apr 30; 250:12-4. PMID: 27107155.
    Citations: 12     Fields:    Translation:Humans
  9. Weiss RD, Potter JS, Griffin ML, Provost SE, Fitzmaurice GM, McDermott KA, Srisarajivakul EN, Dodd DR, Dreifuss JA, McHugh RK, Carroll KM. Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. Drug Alcohol Depend. 2015 May 01; 150:112-9. PMID: 25818060.
    Citations: 47     Fields:    Translation:Humans
  10. Northrup TF, Stotts AL, Green C, Potter JS, Marino EN, Walker R, Weiss RD, Trivedi M. Opioid withdrawal, craving, and use during and after outpatient buprenorphine stabilization and taper: a discrete survival and growth mixture model. Addict Behav. 2015 Feb; 41:20-8. PMID: 25282598.
    Citations: 20     Fields:    Translation:Humans
  11. Potter JS, Dreifuss JA, Marino EN, Provost SE, Dodd DR, Rice LS, Fitzmaurice GM, Griffin ML, Weiss RD. The multi-site prescription opioid addiction treatment study: 18-month outcomes. J Subst Abuse Treat. 2015 Jan; 48(1):62-9. PMID: 25189089.
    Citations: 17     Fields:    Translation:Humans
  12. Weiss RD, Griffin ML, Potter JS, Dodd DR, Dreifuss JA, Connery HS, Carroll KM. Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine-naloxone and standard medical management? Drug Alcohol Depend. 2014 Jul 01; 140:118-22. PMID: 24831754.
    Citations: 14     Fields:    Translation:Humans
  13. Weiss RD, Potter JS, Griffin ML, McHugh RK, Haller D, Jacobs P, Gardin J, Fischer D, Rosen KD. Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain. J Subst Abuse Treat. 2014 Aug; 47(2):140-5. PMID: 24814051.
    Citations: 46     Fields:    Translation:Humans
  14. Rosen K, Gutierrez A, Haller D, Potter JS. Sublingual buprenorphine for chronic pain: a survey of clinician prescribing practices. Clin J Pain. 2014 Apr; 30(4):295-300. PMID: 23727654.
    Citations: 6     Fields:    Translation:Humans
  15. Griffin ML, Dodd DR, Potter JS, Rice LS, Dickinson W, Sparenborg S, Weiss RD. Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder. Am J Drug Alcohol Abuse. 2014 Mar; 40(2):157-62. PMID: 24219166.
    Citations: 12     Fields:    Translation:Humans
  16. Meade CS, Bevilacqua LA, Moore ED, Griffin ML, Gardin JG, Potter JS, Hatch-Maillette M, Weiss RD. Concurrent substance abuse is associated with sexual risk behavior among adults seeking treatment for prescription opioid dependence. Am J Addict. 2014 Jan-Feb; 23(1):27-33. PMID: 24313238; PMCID: PMC3914665.
    Citations: 10     Fields:    Translation:Humans
  17. Brooks AJ, Lokhnygina Y, Meade CS, Potter JS, Calsyn DA, Greenfield SF. Racial/ethnic differences in the rates and correlates of HIV risk behaviors among drug abusers. Am J Addict. 2013 Mar-Apr; 22(2):136-47. PMID: 23414499; PMCID: PMC3576857.
    Citations: 8     Fields:    Translation:Humans
  18. Marino EN, Rosen KD, Gutierrez A, Eckmann M, Ramamurthy S, Potter JS. Impulsivity but not sensation seeking is associated with opioid analgesic misuse risk in patients with chronic pain. Addict Behav. 2013 May; 38(5):2154-7. PMID: 23454878.
    Citations: 15     Fields:    Translation:Humans
  19. Dreifuss JA, Griffin ML, Frost K, Fitzmaurice GM, Potter JS, Fiellin DA, Selzer J, Hatch-Maillette M, Sonne SC, Weiss RD. Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study. Drug Alcohol Depend. 2013 Jul 01; 131(1-2):112-8. PMID: 23333292.
    Citations: 56     Fields:    Translation:HumansCTClinical Trials
  20. McHugh RK, Devito EE, Dodd D, Carroll KM, Potter JS, Greenfield SF, Connery HS, Weiss RD. Gender differences in a clinical trial for prescription opioid dependence. J Subst Abuse Treat. 2013 Jul; 45(1):38-43. PMID: 23313145.
    Citations: 75     Fields:    Translation:Humans
  21. Turk DC, O'Connor AB, Dworkin RH, Chaudhry A, Katz NP, Adams EH, Brownstein JS, Comer SD, Dart R, Dasgupta N, Denisco RA, Klein M, Leiderman DB, Lubran R, Rappaport BA, Zacny JP, Ahdieh H, Burke LB, Cowan P, Jacobs P, Malamut R, Markman J, Michna E, Palmer P, Peirce-Sandner S, Potter JS, Raja SN, Rauschkolb C, Roland CL, Webster LR, Weiss RD, Wolf K. Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations. Pain. 2012 Oct; 153(10):1997-2008. PMID: 22770841.
    Citations: 17     Fields:    Translation:Humans
  22. Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Gardin J, Griffin ML, Gourevitch MN, Haller DL, Hasson AL, Huang Z, Jacobs P, Kosinski AS, Lindblad R, McCance-Katz EF, Provost SE, Selzer J, Somoza EC, Sonne SC, Ling W. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry. 2011 Dec; 68(12):1238-46. PMID: 22065255; PMCID: PMC3470422.
    Citations: 207     Fields:    Translation:Humans
  23. Potter JS, Donovan DM, Weiss RD, Gardin J, Lindblad R, Wakim P, Dodd D. Site selection in community-based clinical trials for substance use disorders: strategies for effective site selection. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):400-7. PMID: 21854283.
    Citations: 10     Fields:    Translation:Humans
  24. Svikis DS, Keyser-Marcus L, Stitzer M, Rieckmann T, Safford L, Loeb P, Allen T, Luna-Anderson C, Back SE, Cohen J, DeBernardi MA, Dillard B, Forcehimes A, Jaffee W, Killeen T, Kolodner K, Levy M, Pallas D, Perl HI, Potter JS, Provost S, Reese K, Sampson RR, Sepulveda A, Snead N, Wong CJ, Zweben J. Randomized multi-site trial of the Job Seekers' Workshop in patients with substance use disorders. Drug Alcohol Depend. 2012 Jan 01; 120(1-3):55-64. PMID: 21802222.
    Citations: 19     Fields:    Translation:Humans
  25. Brooks A, Meade CS, Potter JS, Lokhnygina Y, Calsyn DA, Greenfield SF. Gender differences in the rates and correlates of HIV risk behaviors among drug abusers. Subst Use Misuse. 2010 Dec; 45(14):2444-69. PMID: 20536356.
    Citations: 22     Fields:    Translation:Humans
  26. Potter JS, Chakrabarti A, Domier CP, Hillhouse MP, Weiss RD, Ling W. Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the Clinical Trials Network. J Subst Abuse Treat. 2010 Jun; 38 Suppl 1:S80-6. PMID: 20307799.
    Citations: 17     Fields:    Translation:Humans
  27. Weiss RD, Potter JS, Copersino ML, Prather K, Jacobs P, Provost S, Chim D, Selzer J, Ling W. Conducting clinical research with prescription opioid dependence: defining the population. Am J Addict. 2010 Mar-Apr; 19(2):141-6. PMID: 20163386.
    Citations: 13     Fields:    Translation:Humans
  28. Weiss RD, Potter JS, Provost SE, Huang Z, Jacobs P, Hasson A, Lindblad R, Connery HS, Prather K, Ling W. A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology. Contemp Clin Trials. 2010 Mar; 31(2):189-99. PMID: 20116457.
    Citations: 47     Fields:    Translation:Humans
  29. Potter JS, Prather K, Kropp F, Byrne M, Sullivan CR, Mohamedi N, Copersino ML, Weiss RD. A method to diagnose opioid dependence resulting from heroin versus prescription opioids using the Composite International Diagnostic Interview. Contemp Clin Trials. 2010 Mar; 31(2):185-8. PMID: 20079463.
    Citations: 6     Fields:    Translation:Humans
  30. Woody GE, Poole SA, Subramaniam G, Dugosh K, Bogenschutz M, Abbott P, Patkar A, Publicker M, McCain K, Potter JS, Forman R, Vetter V, McNicholas L, Blaine J, Lynch KG, Fudala P. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA. 2008 Nov 05; 300(17):2003-11. PMID: 18984887; PMCID: PMC2610690.
    Citations: 157     Fields:    Translation:HumansPHPublic Health
  31. Potter JS, Prather K, Weiss RD. Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities. Am J Addict. 2008 Mar-Apr; 17(2):121-5. PMID: 18393055.
    Citations: 48     Fields:    Translation:Humans
  32. Bieber CM, Fernandez K, Borsook D, Brennan MJ, Jamison R, Osgood E, Potter, JS, Thomson HN, Weiss RD, Katz NP. Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: a pilot case-control study. Experimental and Clinical Psychopharmacology (in press). 2008.
  33. Greenfield SF, Potter JS, Lincoln MF, Popuch RE, Kuper L, Gallop RJ. High psychiatric symptom severity is a moderator of substance abuse treatment outcomes among women in single vs. mixed gender group treatment. Am J Drug Alcohol Abuse. 2008; 34(5):594-602. PMID: 18821452.
    Citations: 15     Fields:    Translation:Humans
  34. Potter JS, Shiffman SJ, Weiss RD. Chronic pain severity in opioid-dependence patients. Am J of Drug and Alcohol Abuse. 2008; 34(1):101-7.
  35. Potter JS, Shiffman SJ, Weiss RD. Chronic pain severity in opioid-dependent patients. Am J Drug Alcohol Abuse. 2008; 34(1):101-7. PMID: 18161648.
    Citations: 9     Fields:    Translation:Humans
  36. Potter, JS, Shiffman, SJ, Weiss RD. Chronic pain severity in opioid-dependence patients . Poster to be presented at the annual meeting of the Association for Behavioral and Cognitive Therapies. 2007.
  37. Greenfield SF, Potter JS, Popuch R, Lincoln MF & Gallop RJ. Single-gender group treatment for substance use disorders improves treatment outcomes for women with high psychiatric symptom severity. Poster presented at the annual meeting of The College on Problems on Drug Dependence. 2007.
  38. Forman R, Crits-Christoph P, Kaynak O, Worley M, Hantula DA, Kulaga A, Rotrosen J, Chu M, Gallop R, Potter J, Muchowski P, Brower K, Strobbe S, Magruder K, Chellis AH, Clodfelter T, Cawley M. A feasibility study of a web-based performance improvement system for substance abuse treatment providers. J Subst Abuse Treat. 2007 Dec; 33(4):363-71. PMID: 17499954.
    Citations: 6     Fields:    Translation:Humans
  39. Bieber CM, Thomson HN, Borsook D, Brennan MJ, Butler SF, Fernandez K, Jamison R, Osgood E, Potter JS, Weiss RD, Katz NP. Case-control study on risk factors for prescription opioid abuse among patients with pain. Poster presented at the annual meeting of The College on Problems of Drug Dependence. 2007.
  40. Popuch R, Lincoln MF, Potter JS, Gallop RJ, Greenfield SF. Single-gender group treatment for substance use disorders improves treatment outcomes for women with high levels of depression. Poster presented on Harvard Medical School Psychiatry Research Day. 2007.
  41. Weiss RD, Potter JS, Iannucci R. Inpatient treatment. Galanter M, Kleber HD, eds. The American Psychiatric Press textbook of substance abuse treatment. In press. 2007.
  42. Potter JS, Prather K, Weiss RD . Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities. (In press). Am J on Addictions. 2007.
  43. Shields AL, Howell RT, Potter JS, Weiss RD. The Michigan Alcoholism Screening Test and its shortened form: a meta-analytic inquiry into score reliability. Subst Use Misuse. 2007; 42(11):1783-800. PMID: 17934995.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  44. Potter JS, Kate McHugh BA, Kate Dellaporta, BA, Roger D. Weiss, MC & Shelly Greenfield, MD. Characterizing chronic pain in opioid dependent patients. Poster presented at Early Career Investigators Poster Session at the American Psychological Association Annual Meeting, New Orleans, Louisiana. 2006.
  45. LoCasstro JS, Potter JS, Donovan DM, Couper D, Pope KW. Characteristics of previously untreated alcohol treatment seekers: the COMBINE study. Poster presented at the 28th Annual Scientific Meeting of the Research Society on Alcoholism. 2006.
  46. Potter JS, Janis IB, Weiss RD. Perceptions of Treatment Needs and Experiences of Individual with Co-Occurring Opioid Analgesic Dependence and Chronic Pain: A Qualitative Study. In: Problems of Drug Dependence, Proceedings of the 67th Annual Scientific Meeting, The College of Problems of Drug Dependence. 2005.
  47. Potter JS, Hennessy G, Borrow JA, Greenfield SF, Weiss RD. Substance use histories in patients seeking treatment for controlled-release oxycodone dependence. Drug Alcohol Depend. 2004 Nov 11; 76(2):213-5. PMID: 15488345.
    Citations: 19     Fields:    Translation:Humans
  48. Shields AL, Miller CS, Campfield D, McCall D, Wallace K, Potter JS & Weiss RD. Reliability reporting practices among alcohol screening tools in published reports. Poster presented at the 27th Annual Scientific Meeting of the Research Society on Alcoholism Vancouver, Canada. 2004.
  49. Shields AL, Campfield D, Miller CS, McCall D, Wallace K, Potter JS & Weiss RD. Characterizing the reliability of scores among alcohol screening tools via meta-analytic integration. Poster at the 27th Annual Scientific Meeting of the Research Society on Alcoholism. Vancouver, Canada. 2004.
  50. Potter JS, Prather K, Janis IB, Weiss RD. Moderate to Severe Physical Pain and Associated Characteristics in Persons Seeking Treatment for Substance Use Disorders in Four Modalities. In: Problems of Drug Dependence, Proceedings of the 66th Annual Scientific Meeting, The College of Problems of Drug Dependence. 2004.
  51. Weiss RD, Potter JS. Inpatient treatment. Galanter M, Kleber HD, eds. The American Psychiatric Press textbook of substance abuse treatment. 2004.
  52. Shields AL, Miller CS, Campfield D, McCall C, Wallace K, Potter JS, Weiss RD. Reliability reporting practices among alcohol screening tools in published reports. Alcoholism-Clinical and Experimental Research. 2004; 29(5 Suppl.S):110A-110A.
  53. Shields, AL, Campfield D, Miller CS, McCall C, Wallace K, Potter JS, Weiss RD. Characterizing the reliability of scores among alcohol screening tools via meta-analytic integration. Alcoholism-Clinical and Experimental Research. 2004; 29(5 Suppl. S):109A-109A.
  54. Potter JS, Hennessy G, Borrow JA, Greenfield S, Weiss RD. Characteristics of patients with oxyContin dependence. In: Problems of Drug Dependence. Proceedings of the 65th Annual Scientific Meeting, The College on Problems of Drug Dependence. 2003.
  55. DiIorio C, Hartwell T, Hansen N, & The NIMH Multisite HIV Prevention Trial Group. Childhood sexual abuse and risk behaviors among men at high risk for HIV infection. Am J of Public Health. 2002; 92(2):214-219.
  56. Weiss RD & Potter JS. Acamprosate in the treatment of alcohol dependence. American Association of Addiction Psychiatry Newsletter Insert. 2002.
  57. DiIorio C, Dudley WN, Kelly M, Soet JE, Mbwara J, Sharpe Potter J. Social cognitive correlates of sexual experience and condom use among 13- through 15-year-old adolescents. J Adolesc Health. 2001 Sep; 29(3):208-16. PMID: 11524220.
    Citations: 37     Fields:    Translation:Humans
  58. Celentano DD, DiIorio C, Hartwell T, Kelly J, Magana R, Maibach E, Ivanoff A, El-Bassel N, Ferreira-Pinto JB, Jemmott JB, Jemmott LS, Martin R, Murphy D, Raffaelli M, Rompalo AM, Schlenger W, Skiiema F, Somlai A, Alford K, Hackl K, Parra M, Sharpe-Potter J, Witte S, Hansen N, McFadden D, Perritt R, Poole WK, Gaydos D, Quinn TC, Mithick L, Roberts S, Stover E, Bellack AS, Coates T, Crano WD, Francis D, Green SB, Moras K. A test of factors mediating the relationship between unwanted sexual activity during childhood and risky sexual practices among women enrolled in the NIMH Multisite HIV Prevention Trial. Women and Health. 2001; 11(1-2):163-180.
  59. Celentano DD, Dilorio C, Hartwell T, Kelly J, Magana R, Maibach E, O'Leary A, Pequegnat W, Rotheram-Borus MJ, Schilling R, Amsel J, El-Bassel N, Ferreira-Pinto JB, Gleghom A, Ivanoff A, Jemmott JB, Jemmott LS, Martin R, Miller S, Murphy D, Raffaelli M, Rampalo AM, Schlenger W, Sikkema K, Somlai A, Alford K, Allende-Ramos C, Hackl K, Kuklinski M, Langabeer KA, Lee MB, Lopez E, Nava P, Parra M, Pranke J, Reid H, Sharpe-Potter J, Witte S, Villasenor Y, Wight RG, Hansen N, LaVange L, McFadden D, Perritt R, Poole WK, Gaydos C, Quinn TC, Mithick L, Roberts W, Stover E, Bellack AS, Coates T, Crano WD, Francis D, Green SB, Moras K. Social-cognitive theory mediators of behavior change in the NIMH Multisite HIV Prevention Trial. Health Psychology. 2001; 29(5):369-376.
  60. NIMH Multisite HIV Prevention Trial Group . The NIMH multisite HIV prevention trial: Reducing HIV sexual risk behavior. Science. 1998; 29(3):208-216.
  61. Thompson NJ, Potter JS, Sanderson CA, Maibach EW. The relationship of sexual abuse and HIV risk behaviors among heterosexual adult female STD patients. Child Abuse Negl. 1997 Feb; 21(2):149-56. PMID: 9056094.
    Citations: 31     Fields:    Translation:Humans
  62. NIMH Multisite HIV Prevention Trial Group. Conceptual basis and procedures for the intervention in a multisite HIV prevention trial. AIDS. 1997; 11(Suppl 2):S29-35.
  63. NIMH Multisite HIV Prevention Trial Group. Endpoints and other measures in a multisite HIV prevention trial: rationale and psychometric properties. AIDS. 1997; 11(Suppl 2):S37-47.
  64. NIMH Multisite HIV Prevention Trial Group. Demographic and behavioral predictors of sexual risk in a multisite HIV prevention trial. AIDS. 1997; 11(Suppl 2):S21-27.
  65. NIMH Multisite HIV Prevention Trial Group. Quality control and quality assurance in HIV prevention research: model from a multisite HIV prevention trial. AIDS. 1997; 11(Suppl 2):S49-53.
  66. NIMH Multisite HIV Prevention Trial Group. Definition of adverse reactions in clinical trials of a behavioral intervention. AIDS. 1997; 11(Suppl 2,):S55-67.
  67. NIMH Multisite HIV Prevention Trial Group. Methodological overview of a multisite HIV prevention trial for populations at risk for HIV. AIDS. 1997; 11(Suppl 2):S1-11.
  68. NIMH Multisite HIV Prevention Trial Group. Screening, recruiting and predicting retention of participants in a multisite HIV prevention trial. AIDS. 1997; 11(Suppl 2):S13-19.
  69. NIMH Multisite HIV Prevention Trial Group. Collecting sexually transmitted disease clinic chart data in multisite studies. AIDS. 1997; 11(Suppl 2):S59-63.
  70. Potter JS, Blount RL, Manimala MR, Cohen LL, Frank NC & Bunke V. The Child-Adult Medical Procedure Interaction Scale-Short Form: Validity of a brief rating scale for assessing behavior during painful medical procedures. Paper presented at the annual meeting of the Association for the Advancement of Behavior Therapy, NY, NY. 1996.
  71. Rogers M, Wilson AE, Calhoun K, Potter JS & McAnulty R. Sexually coercive men and sexual risk behaviors related to HIV risk. Paper presented at the annual meeting of the Association for the Advancement of Behavior Therapy, NY, NY. 1996.
  72. Brown RT, Chance S, Dabbs JM, Casey R, & Potter JS. Testosterone and Children with Disruptive Behavior Disorders: Behavioral and Cognitive Correlates. Paper presented at the annual meeting of ACADS, Sydney, Australia. 1995.
  73. Sharpe JN, Brown RT, Thompson NJ, Eckman J. Predictors of coping with pain in mothers and their children with sickle cell syndrome. J Am Acad Child Adolesc Psychiatry. 1994 Nov-Dec; 33(9):1246-55. PMID: 7995790.
    Citations: 3     Fields:    Translation:Humans
  74. Sharpe JN, Brown RT, Thompson NJ & Eckman J. Predictors of coping with pain in children and their mothers with sickle cell syndrome. Paper presented at the annual meeting of the National Sickle Cell Conference, NY, NY. 1994.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Potter's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (160)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.